IACS-52825

N/A

Report date: 2023/07/26 10:28:00
NME

Base Information

Drug NameIACS-52825
Drug Alias NameIACS-52825
ClassificationSmall molecules
Mechanisms of ActionMitogen-activated protein kinase kinase kinase 12 inhibitors
TargetsMitogen-activated protein kinase kinase kinase 12
Therapy Area/IndicationsPeripheral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Texas MD Anderson Cancer Center
Inactive CompaniesN/A
Active IndicationsPeripheral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A